CSI Market
Sign In | Register

Neurogene Inc (NGNE) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access NGNE Annual Cash Flow →
The cash flow figures below highlight longer-term patterns in how Neurogene Inc manages cash inflows and outflows over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-65.42
Depreciation & amortization1.66
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Asset Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation11.49
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Fee And Penalty On Bank Loan Repayment-
Amortization Of Preferred Stock Discount-
Gain Loss On Derivative Instruments Net Pretax-
Foreign Currency Transaction Gain Loss And Others-
Operating Lease Right Of Use Asset Amortization-
Write Off Of Right Of Use Asset Upon Lease Termination-
Increase Decrease In Operating Lease Right Of Use Assets-
Operating Lease Impairment Loss-
Asset Acquisition Bargain Purchase Gain Recognized Amount-
Operating Lease Expense0.19
Finance Lease Right Of Use Asset Amortization0.01
Increase Decrease In Contingent Value Rights Liability-0.66
Increase Decrease In Operating Lease Liability-0.76
Income taxes0.00
Losses/ -gains on Investments net0.00
Accounts Receivable0.00
Increase (Decrease) in Accounts Payable1.30
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities4.45
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.77
Other Working Capital0.07
Other Noncash Income (Expense)0.00
Other net0.72
Payments for (Proceeds from) Other Operating Activities-4.93
Discontinued operations0.00
Net Cash flow from Operating Activities-49.88
Investing Activities
Capital Expenditures-0.64
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Held-to-maturity Securities249.14
Payments to Acquire Held-to-maturity Securities-196.16
Real Estate Investments0.00
Payments Of Merger Related Costs Investing Activities-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Cash Acquired from Acquisition0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities52.34
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.27
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net5.90
Special Voting Common Stock Issued Value-
Finance Lease Principal Payments-0.01
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities6.18
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-50.52
Total Cash Flow8.64
4 historic quarters locked

Sign in to unlock the full Neurogene Inc cash flow history.

Sign In Create Free Account

About Neurogene Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001404644-26-000059

Figures are derived from filed reports and may be restated. Historical data is subject to revision.